It's hard to measure a tiny, fleeting gas called nitric oxide inside the body, but new high-tech tools are now letting scientists track where and when it shows up in the heart, brain, and tumors.
Claim Language
Language Strength
probability
Uses probability language (may, likely, can)
The claim uses 'remains challenging' to indicate difficulty (not impossibility) and 'are enabling' to suggest capability or potential, not certainty—both are probabilistic language indicating possibility rather than definitive outcome.
Context Details
Domain
medicine
Population
in_vitro
Subject
The detection of nitric oxide and its derivatives in vivo
Action
remains challenging due to its instability and low concentration, but emerging technologies are enabling
Target
real-time, spatially resolved monitoring in cardiovascular, neurological, and cancer contexts
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
Nitric Oxide Signaling and Sensing in Age-Related Diseases
This study doesn’t test new gadgets, but it says measuring nitric oxide in the body is hard — and we really need better ways to do it, especially for diseases like heart problems and cancer. That matches the claim that new tools are helping us finally track it in real time.